Skip to content

The Influence of Perioperative Optimisation to the Hip Arthroplasty Outcomes

The Influence of Perioperative Optimisation to the Primary Hip Arthroplasty Outcomes

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03260309
Enrollment
100
Registered
2017-08-24
Start date
2013-10-31
Completion date
2017-07-31
Last updated
2017-08-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hip Osteoarthritis

Brief summary

Success of the hip arthroplasty depends on the measures that optimize perioperative conditions.It is planned to evaluate semi-closed loop system in the hip arthroplasty surgery.

Detailed description

Success of the total hip arthroplasty depends on the measures that optimize perioperative conditions. They increase the emotional stress of the staff and error probability. It is planned to evaluate semi-closed loop infusion system, its adaption for infusion application's influence to near and far treatment outcomes done by prospective randomized clinical trial. This is done by performing total hip arthroplasty. It's expected to evaluate the semi-closed loop system's influence on the doctor's emotional tension during the decision making.

Interventions

PROCEDURESemi-closed loop infusion system tactic.

Semi -closed loop infusion system tactic.Use volume loading test twice (before surgery and 12hrs postoperatively). Computer provides advisory hypotension treatment algorithm. Computer provides advisory anemia treatment algorithm. Programmed iv fluid and blood infusions system ,,Belmont Rapid Infuser and programmable syringe pump for adrenaline infusion.

PROCEDURERoutine infusion therapy tactic

Routine re-hydration bolus before surgery. Routine treatment of hypotension. Routine treatment of anemia.

Sponsors

Karolinska Institutet
CollaboratorOTHER
Kaunas University of Technology
CollaboratorOTHER
Vilnius University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
TRIPLE (Subject, Caregiver, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
50 Years to 85 Years
Healthy volunteers
No

Inclusion criteria

* Patients with osteoarthritis of the hip undergoing hip arthroplasty with spinal - epidural anesthesia * Age \>50 and \<85 years * ASA (American Society of Anesthesiology Classification) II physical status * Start of operation no later than 09:00 * Signed informed consent form

Exclusion criteria

* Age \<50 and \>85 yers * BMI (Body Mass Index) \<20 and \>40 kg/m2 * ASA I and ASA\>II physical status * History of a bleeding disorder * Anemia before surgery Hb\<110 g/l * Intravascular fluid infusion within 24 hours before study * Diabetes mellitus * Previous open hip surgery * Psychiatric illness (intake of other psychiatric medication than selective serotonin reuptake inhibitors) * Alcohol intake 5 U daily * Contraindication to spinal - epidural anesthesia * Surgery not by project surgeon * Start of operation later than 09:00 * Atrial fibrillation * Narcotic addiction * History of DVT (Deep Vein Thrombosis), thromboembolic complications, acute cardiac insufficiency * Participation in the other study

Design outcomes

Primary

MeasureTime frameDescription
The efficiency of semi-closed loop infusion systemBefore the surgery and 12 hrs postoperativelyDetermine the ratio of doctor's approved and rejected computer suggestions

Secondary

MeasureTime frameDescription
Coagulation activityBefore (baseline) the surgery and 24hrs postoperativelyCoagulation activity is investigated thromboelastically
Infused fluid and red blood cell volumeBefore the surgery and 24hrs postoperativelyRepeated rehydration bolus (sol.Ringeri 2,5ml/kg), supportive fluid infusion (sol.NaCl 0,9% 1,5 ml/kg/hrs); evaluation of signs of anemia intolerance if Hb \< 110 g/l
Wound healingWithin 6 days postoperativelyEvaluation of wound tissue condition, measurement of drainage fluid volume
Perioperative blood lossBefore (baseline) the surgery,during surgery and 24hrs postoperativelyNon-invasive measurement of Hb (Masimo technology). Laboratory hemoglobin determination, evaluation of the bleeding volume
Haemodynamic stabilityBefore (baseline) the surgery and 12 hrs postoperativelyInvasive measurement of arterial blood pressure
ComplicationsWithin 6 days postoperativelyRegistration of all complications
Dosage physical exercise sampleWithin 6 days postoperativelyTimed up and go test

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026